The Vancouver-based investor relations agency, irlabs, has been acquired by shareholder engagement and advisory company, Alliance Advisors. The acquisition is set to extend irlabs’ influence across North America and internationally. Founded in 2021 by Alyssa Barry and Caroline Sawamoto, irlabs has grown to 25 employees and is recognized for its innovative business model and customer […]
Rakovina Therapeutics
Q+A with Rakovina Therapeutics’ Co-Founder Jeffrey Bacha on Leveraging AI Precision Medicine to Fight Cancer
Vancouver’s Rakovina Therapeutics (RKV:TSXV) is a Canadian biotechnology company focused on developing innovative therapies for the treatment of cancer. It was founded in 2021 by Jeffrey Bacha, a serial entrepreneur with startups and companies operating in the biotechnology and life sciences fields. Earlier this year, Bacha and the Rakovina team made a strategic pivot as […]
Rakovina Therapeutics Advances AI in Cancer Drug Research
Vancouver’s Rakovina Therapeutics is evolving their business model to place the biopharmaceutical company at the forefront of artificial intelligence-driven (AI) precision medicine for cancer drug development research. Dedicated to improving the lives of cancer patients through the development of novel DNA-damage response inhibitor therapeutics, Rakovina has entered into a collaboration agreement with Dr. Artem Cherkasov […]